BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30026594)

  • 1. Small molecule activator of Nm23/NDPK as an inhibitor of metastasis.
    Lee JJ; Kim HS; Lee JS; Park J; Shin SC; Song S; Lee E; Choi JE; Suh JW; Lee H; Kim EE; Seo EK; Shin DH; Lee HY; Lee HY; Lee KJ
    Sci Rep; 2018 Jul; 8(1):10909. PubMed ID: 30026594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nm23-H1 activator phenylbutenoid dimer exerts cytotoxic effects on metastatic breast cancer cells by inducing mitochondrial dysfunction only under glucose starvation.
    Kim B; Lee JJ; Shin JS; Suh JW; Jung S; Hwang GS; Lee HY; Lee KJ
    Sci Rep; 2021 Dec; 11(1):23549. PubMed ID: 34876614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation.
    Kim B; Lee KJ
    Exp Mol Med; 2021 Mar; 53(3):346-357. PubMed ID: 33753879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
    Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
    Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.
    Almgren MA; Henriksson KC; Fujimoto J; Chang CL
    Mol Cancer Res; 2004 Jul; 2(7):387-94. PubMed ID: 15280446
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Felix I; Lomada SK; Barth H; Wieland T
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis.
    Mátyási B; Farkas Z; Kopper L; Sebestyén A; Boissan M; Mehta A; Takács-Vellai K
    Pathol Oncol Res; 2020 Jan; 26(1):49-61. PubMed ID: 31993913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
    Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
    Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity.
    Peuchant E; Bats ML; Moranvillier I; Lepoivre M; Guitton J; Wendum D; Lacombe ML; Moreau-Gaudry F; Boissan M; Dabernat S
    FASEB J; 2017 Apr; 31(4):1531-1546. PubMed ID: 28077425
    [No Abstract]   [Full Text] [Related]  

  • 11. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple regulation of metastasis suppressor NM23-H1 in cancer.
    Yu L; Wang X; Zhang W; Khan E; Lin C; Guo C
    Life Sci; 2021 Mar; 268():118995. PubMed ID: 33421524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration.
    Murakami M; Meneses PI; Lan K; Robertson ES
    Cancer Biol Ther; 2008 May; 7(5):677-88. PubMed ID: 18728402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The regulation of nm23-H1/NDPK-A in different processes of regional lymph node metastases of oral squamous cell carcinomas].
    Yang Z; Wen Y; Pu P
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):263-6. PubMed ID: 14513578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulators affecting the metastasis suppressor activity of Nm23-H1.
    Kim HD; Youn B; Kim TS; Kim SH; Shin HS; Kim J
    Mol Cell Biochem; 2009 Sep; 329(1-2):167-73. PubMed ID: 19377884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
    Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
    Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dosage-dependent effect exerted by the NM23-H1/H2 homolog NDK-1 on distal tip cell migration in C. elegans.
    Farkas Z; Fancsalszky L; Saskői É; Gráf A; Tárnok K; Mehta A; Takács-Vellai K
    Lab Invest; 2018 Feb; 98(2):182-189. PubMed ID: 28920944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
    Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
    Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
    Wong KM; Song J; Wong YH
    Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.